4qbz
From Proteopedia
(Difference between revisions)
Line 7: | Line 7: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qbz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qbz OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qbz RCSB], [http://www.ebi.ac.uk/pdbsum/4qbz PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qbz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qbz OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qbz RCSB], [http://www.ebi.ac.uk/pdbsum/4qbz PDBsum]</span></td></tr> | ||
</table> | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/TLR8_HUMAN TLR8_HUMAN]] Key component of innate and adaptive immunity. TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response.<ref>PMID:17932028</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 19: | Line 21: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: Ohto, U | + | [[Category: Ohto, U]] |
- | [[Category: Shimizu, T | + | [[Category: Shimizu, T]] |
- | [[Category: Tanji, H | + | [[Category: Tanji, H]] |
[[Category: Antiviral and antitumor drug binding]] | [[Category: Antiviral and antitumor drug binding]] | ||
[[Category: Glycosylation]] | [[Category: Glycosylation]] |
Revision as of 15:31, 24 December 2014
Crystal structure of human TLR8 in complex with DS-802
|
Categories: Ohto, U | Shimizu, T | Tanji, H | Antiviral and antitumor drug binding | Glycosylation | Innate immunity | Leucine rich repeat | Rna binding | Rna binding protein | Rna receptor | Rna recognition | Secreted | Ssrna | Structure-based ligand design | Tlr8 and tlr7 agonist | Vaccine adjuvant